Skip to main content

Marty Liggett’s advice for CEOs weighing big, risky ideas

Helping to conquer a labor shortage, improving the diagnosis and treatment of sickle cell disease in under-resourced countries and leading a global expansion are all hallmarks of Martha “Marty” Liggett’s tenure at the American Society of Hematology (ASH).Liggett’s daring decisions — such as leading ASH to launch an apprenticeship program that would typically be run by the federal government — were made possible in part due to healthy reserves. Liggett grew the annual operating budget from $5.5 million to just more than $130 million, achieving her goal of reserves that equal or exceed one year’s operating budget.Liggett, the 2026 CEO Update and Association TRENDS… Read More